Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.

Monagle P, Lensing AWA, Thelen K, Martinelli I, Male C, Santamaría A, Samochatova E, Kumar R, Holzhauer S, Saracco P, Simioni P, Robertson J, Grangl G, Halton J, Connor P, Young G, Molinari AC, Nowak-Göttl U, Kenet G, Kapsa S, Willmann S, Pap AF, Becka M, Twomey T, Beyer-Westendorf J, Prins MH, Kubitza D; EINSTEIN-Jr Phase 2 Investigators.

Lancet Haematol. 2019 Aug 13. pii: S2352-3026(19)30161-9. doi: 10.1016/S2352-3026(19)30161-9. [Epub ahead of print]

PMID:
31420317
2.

Replacement Therapy in Patients with Von Willebrand Disease-Indications and Monitoring.

Nowak-Göttl U, Miesbach W, Koscielny J, Dempfle CE, Maegele M, Prondzinski MVD, Westrup D, Spannagl M.

Hamostaseologie. 2019 Jul 30. doi: 10.1055/s-0039-1692688. [Epub ahead of print]

PMID:
31364093
3.

[Cerebral venous and sinus thrombosis : S2k guidelines].

Weimar C, Holzhauer S, Knoflach M, Koennecke HC, Masuhr F, Mono ML, Niederstadt T, Nowak-Göttl U, Schellong SM, Kurth T.

Nervenarzt. 2019 Apr;90(4):379-387. doi: 10.1007/s00115-018-0654-6. Review. German. No abstract available.

PMID:
30758512
4.

Recurrent stroke: the role of thrombophilia in a large international pediatric stroke population.

deVeber G, Kirkham F, Shannon K, Brandão L, Sträter R, Kenet G, Clausnizer H, Moharir M, Kausch M, Askalan R, MacGregor D, Stoll M, Torge A, Dlamini N, Ganesan V, Prengler M, Singh J, Nowak-Göttl U.

Haematologica. 2019 Aug;104(8):1676-1681. doi: 10.3324/haematol.2018.211433. Epub 2019 Jan 24.

5.

Psychometric Properties of a Modified KINDL-R Questionnaire for Adolescents and Adults, and Construction of a Brief Version, the KINDL-A(dult)B(rief) Questionnaire, KINDL-AB.

Neuner B, Krampe H, McCarthy WJ, Reinke S, Kowalski D, Clausnizer H, Shneyder M, Rocke A, Nowak-Göttl U.

Acta Haematol. 2018;140(1):1-9. doi: 10.1159/000490408. Epub 2018 Jul 13.

6.

Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study.

Witten A, Bolbrinker J, Barysenka A, Huber M, Rühle F, Nowak-Göttl U, Garbe E, Kreutz R, Stoll M.

J Mol Med (Berl). 2018 Aug;96(8):765-775. doi: 10.1007/s00109-018-1661-6. Epub 2018 Jun 22.

PMID:
29934777
7.

Hemostasis in the Very Young.

Kenet G, Barg AA, Nowak-Göttl U.

Semin Thromb Hemost. 2018 Oct;44(7):617-623. doi: 10.1055/s-0038-1660852. Epub 2018 Jun 18. Review.

PMID:
29913536
8.

Thrombophilia testing in children: What and when should be tested?

Nowak-Göttl U, van Ommen H, Kenet G.

Thromb Res. 2018 Apr;164:75-78. doi: 10.1016/j.thromres.2018.02.136. Epub 2018 Feb 21. Review.

PMID:
29518638
9.

Lack of evidence for the transmission of hepatitis E virus by coagulation factor concentrates based on seroprevalence data.

Juhl D, Nowak-Göttl U, Blümel J, Görg S, Hennig H.

Transfus Med. 2018 Dec;28(6):427-432. doi: 10.1111/tme.12498. Epub 2017 Dec 27.

PMID:
29280212
10.

Editorial for special pediatric hemostasis issue BCMD.

Kenet G, Nowak-Göttl U.

Blood Cells Mol Dis. 2017 Sep;67:1. doi: 10.1016/j.bcmd.2017.09.010. No abstract available.

PMID:
29113682
11.

Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Test.

van Ommen CH, Nowak-Göttl U.

Front Pediatr. 2017 Mar 14;5:50. doi: 10.3389/fped.2017.00050. eCollection 2017. Review.

12.

The VKORC1 and CYP2C9 genotypes significantly effect Vitamin K antagonist dosing only in patients over the age of 20years.

Nowak-Göttl U, Dietrich K, Kruempel A, Geisen C, Mitchell LG.

Blood Cells Mol Dis. 2017 Sep;67:54-58. doi: 10.1016/j.bcmd.2016.12.012. Epub 2016 Dec 30.

PMID:
28284562
13.

Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotype.

Boeckelmann D, Hengartner H, Greinacher A, Nowak-Göttl U, Sachs UJ, Peter K, Sandrock-Lang K, Zieger B.

Blood Cells Mol Dis. 2017 Sep;67:69-74. doi: 10.1016/j.bcmd.2017.01.010. Epub 2017 Jan 22.

PMID:
28131619
14.

Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates.

Strauss T, Elisha N, Ravid B, Rosenberg N, Lubetsky A, Levy-Mendelovich S, Morag I, Nowak Göttl U, Kenet G.

Blood Cells Mol Dis. 2017 Sep;67:14-17. doi: 10.1016/j.bcmd.2016.12.013. Epub 2016 Dec 29.

PMID:
28087247
15.

Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population.

Nowak-Göttl U, Limperger V, Kenet G, Degenhardt F, Arlt R, Domschikowski J, Clausnizer H, Liebsch J, Junker R, Steppat D.

Blood Cells Mol Dis. 2017 Sep;67:2-13. doi: 10.1016/j.bcmd.2016.11.012. Epub 2016 Dec 5.

PMID:
28017497
16.

Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism.

Rühle F, Witten A, Barysenka A, Huge A, Arning A, Heller C, Krümpel A, Mesters R, Franke A, Lieb W, Riemenschneider M, Hiersche M, Limperger V, Nowak-Göttl U, Stoll M.

Blood. 2017 Feb 9;129(6):783-790. doi: 10.1182/blood-2016-07-728840. Epub 2016 Dec 23.

17.

Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years?

Kenet G, Limperger V, Shneyder M, Nowak-Göttl U.

Blood Cells Mol Dis. 2017 Sep;67:18-22. doi: 10.1016/j.bcmd.2016.12.003. Epub 2016 Dec 14. Review.

PMID:
28010922
18.

Health-related quality of life in children, adolescents and adults with hereditary and acquired bleeding disorders.

Nowak-Göttl U, Clausnizer H, Kowalski D, Limperger V, Krümpel A, Shneyder M, Reinke S, Rocke A, Juhl D, Steppat D, Krause M.

Blood Cells Mol Dis. 2017 Sep;67:96-101. doi: 10.1016/j.bcmd.2016.11.010. Epub 2016 Nov 12.

PMID:
27865683
19.

Impact of high risk thrombophilia status on recurrence among children and adults with VTE: An observational multicenter cohort study.

Brüwer G, Limperger V, Kenet G, Klostermeier UC, Shneyder M, Degenhardt F, Finckh U, Heller C, Holzhauer S, Trappe R, Kentouche K, Knoefler R, Kurnik K, Krümpel A, Lauten M, Manner D, Mesters R, Junker R, Nowak-Göttl U.

Blood Cells Mol Dis. 2016 Nov;62:24-31. doi: 10.1016/j.bcmd.2016.10.024. Epub 2016 Nov 5.

PMID:
27838551
20.

Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network.

Hartmann S, Biliouris K, Lesko LJ, Nowak-Göttl U, Trame MN.

CPT Pharmacometrics Syst Pharmacol. 2016 Oct;5(10):554-564. doi: 10.1002/psp4.12111. Epub 2016 Sep 20.

21.

Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.

Krause M, Henningsen A, Torge A, Juhl D, Junker R, Kenet G, Kowalski D, Limperger V, Mesters R, Anonymous, Rocke A, Shneyder M, Clausnizer H, Schiesewitz H, Nowak-Göttl U.

Thromb Res. 2016 Dec;148:145-151. doi: 10.1016/j.thromres.2016.09.007. Epub 2016 Sep 13. No abstract available.

PMID:
27687905
22.

Haemostasis - an indispensable, cross-sectional medical discipline.

Nowak-Göttl U, Kehrel BE.

Thromb Haemost. 2016 Sep 27;116(4):595-6. doi: 10.1160/TH16-08-0648. Epub 2016 Aug 25. No abstract available.

PMID:
27609222
23.

Rare Variants in the ADAMTS13 Von Willebrand Factor-Binding Domain Contribute to Pediatric Stroke.

Stoll M, Rühle F, Witten A, Barysenka A, Arning A, Strauss C, Nowak-Göttl U.

Circ Cardiovasc Genet. 2016 Aug;9(4):357-67. doi: 10.1161/CIRCGENETICS.115.001184. Epub 2016 Jul 13.

PMID:
27412500
24.

Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort study.

Limperger V, Kenet G, Goldenberg NA, Heller C, Holzhauer S, Junker R, Klostermeier UC, Knoefler R, Kurnik K, Krümpel A, Mesters R, Stach M, Young G, Nowak-Göttl U.

Br J Haematol. 2016 Oct;175(1):133-40. doi: 10.1111/bjh.14192. Epub 2016 Jun 22.

PMID:
27329967
25.

Health-Related Quality of Life in Children and Adolescents with Hereditary Bleeding Disorders and in Children and Adolescents with Stroke: Cross-Sectional Comparison to Siblings and Peers.

Neuner B, von Mackensen S, Holzhauer S, Funk S, Klamroth R, Kurnik K, Krümpel A, Halimeh S, Reinke S, Frühwald M, Nowak-Göttl U.

Biomed Res Int. 2016;2016:1579428. doi: 10.1155/2016/1579428. Epub 2016 May 15.

26.

Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.

Werwitzke S, Geisen U, Nowak-Göttl U, Eichler H, Stephan B, Scholz U, Holstein K, Klamroth R, Knöbl P, Huth-Kühne A, Bomke B, Tiede A.

J Thromb Haemost. 2016 May;14(5):940-7. doi: 10.1111/jth.13304. Epub 2016 Apr 22.

27.

ADAMTS genes and the risk of cerebral aneurysm.

Arning A, Jeibmann A, Köhnemann S, Brokinkel B, Ewelt C, Berger K, Wellmann J, Nowak-Göttl U, Stummer W, Stoll M, Holling M.

J Neurosurg. 2016 Aug;125(2):269-74. doi: 10.3171/2015.7.JNS154. Epub 2016 Jan 8.

PMID:
26745484
28.

Bleeding issues in neonates and infants - update 2015.

Nowak-Göttl U, Limperger V, Bauer A, Kowalski D, Kenet G.

Thromb Res. 2015 Feb;135 Suppl 1:S41-3. doi: 10.1016/S0049-3848(15)50440-4. Epub 2015 Feb 9. Review.

PMID:
25903533
29.

End-stage renal disease and thrombophilia.

Bauer A, Limperger V, Nowak-Göttl U.

Hamostaseologie. 2016 May 10;36(2):103-7. doi: 10.5482/HAMO-14-11-0063. Epub 2015 Feb 2. Review.

PMID:
25639843
30.

Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A. A patient-level meta-analysis.

Marcucci M, Mancuso ME, Santagostino E, Kenet G, Elalfy M, Holzhauer S, Bidlingmaier C, Escuriola Ettingshausen C, Iorio A, Nowak-Göttl U.

Thromb Haemost. 2015 May;113(5):958-67. doi: 10.1160/TH14-07-0621. Epub 2015 Jan 29.

PMID:
25631402
31.

Proteomic and other mass spectrometry based "omics" biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: current state, unmet needs, and future directions.

Goldenberg NA, Everett AD, Graham D, Bernard TJ, Nowak-Göttl U.

Proteomics Clin Appl. 2014 Dec;8(11-12):828-36. doi: 10.1002/prca.201400062. Review.

PMID:
25379629
32.

Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study.

Ichord RN, Benedict SL, Chan AK, Kirkham FJ, Nowak-Göttl U; International Paediatric Stroke Study Group.

Arch Dis Child. 2015 Feb;100(2):174-9. doi: 10.1136/archdischild-2014-306382. Epub 2014 Oct 6.

PMID:
25288688
33.

Role of protein S deficiency in children with venous thromboembolism. An observational international cohort study.

Klostermeier UC, Limperger V, Kenet G, Kurnik K, Alhenc Gelas M, Finckh U, Junker R, Heller C, Zieger B, Knöfler R, Holzhauer S, Mesters R, Krümpel A, Nowak-Göttl U.

Thromb Haemost. 2015 Feb;113(2):426-33. doi: 10.1160/TH14-06-0533. Epub 2014 Oct 2.

PMID:
25272994
34.

Challenging aspects of managing hemostasis in adolescents.

Nowak-Göttl U, Kenet G.

Acta Haematol. 2014;132(3-4):326-30. doi: 10.1159/000360237. Epub 2014 Sep 10. Review.

PMID:
25228558
35.

Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study.

Limperger V, Klostermeier UC, Kenet G, Holzhauer S, Alhenc Gelas M, Finckh U, Junker R, Heller C, Zieger B, Kurnik K, Knöfler R, Mesters R, Halimeh S, Nowak-Göttl U.

Br J Haematol. 2014 Nov;167(3):385-93. doi: 10.1111/bjh.13039. Epub 2014 Jul 18.

PMID:
25039884
36.

Clinical and laboratory characteristics of paediatric and adolescent index cases with venous thromboembolism and antithrombin deficiency. An observational multicentre cohort study.

Limperger V, Franke A, Kenet G, Holzhauer S, Picard V, Junker R, Heller C, Gille C, Manner D, Kurnik K, Knoefler R, Mesters R, Halimeh S, Nowak-Göttl U.

Thromb Haemost. 2014 Sep 2;112(3):478-85. doi: 10.1160/TH14-02-0149. Epub 2014 Jun 26.

PMID:
24966143
37.

[Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].

Nowak-Göttl U, Langer F, Limperger V, Mesters R, Trappe RU.

Dtsch Med Wochenschr. 2014 Jun;139(24):1301-6. doi: 10.1055/s-0034-1370110. Epub 2014 Jun 3. Review. German.

PMID:
24892468
38.

Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A--an Israeli-German multicenter database study.

Kenet G, Bidlingmaier C, Bogdanova N, Ettingshausen CE, Goldenberg N, Gutsche S, Halimeh S, Holzhauer S, Kurnik K, Limperger V, Junker R, Nowak-Göttl U.

Thromb Res. 2014 Apr;133(4):544-9. doi: 10.1016/j.thromres.2014.01.005. Epub 2014 Jan 17.

39.

Subcutaneous protein C concentrate in the management of severe protein C deficiency--experience from 12 centres.

Minford A, Behnisch W, Brons P, David M, Gomez Gomez N, Hertfelder HJ, Kruempel A, Kurnik K, Mathias M, Molines Honrubia A, Monagle P, Morgan M, Nowak-Göttl U, Olivieri M.

Br J Haematol. 2014 Feb;164(3):414-21. doi: 10.1111/bjh.12640.

PMID:
24422725
40.

Advances in understanding stroke risk in children--a geneticist's view.

Stoll M, Rühle F, Nowak-Göttl U.

Br J Haematol. 2014 Mar;164(5):636-45. doi: 10.1111/bjh.12706. Epub 2013 Dec 19. Review.

PMID:
24354735
41.

[Thromboembolisms in childhood and adolescence].

Limperger V, Nowak-Göttl U.

Kinderkrankenschwester. 2013 Oct;32(10):396-401. German. No abstract available.

PMID:
24303594
42.

Risk factors for high-titer inhibitor development in children with hemophilia A: results of a cohort study.

Halimeh S, Bidlingmaier C, Heller C, Gutsche S, Holzhauer S, Kenet G, Kurnik K, Manner D, Iorio A, Nowak-Göttl U.

Biomed Res Int. 2013;2013:901975. doi: 10.1155/2013/901975. Epub 2013 Oct 2.

43.

Efficacy and safety of Wilate in paediatric VWD patients under 6 years of age - results of a prospective multicentre clinical study including recovery information.

Nowak-Göttl U, Krümpel A, Russo A, Jansen M.

Haemophilia. 2013 Nov;19(6):887-92. doi: 10.1111/hae.12237. Epub 2013 Aug 6.

PMID:
23919249
44.

Testing for apolipoprotein(a) phenotype using isoelectric focusing and immunoblotting technique.

Langer C, Tambyrayah B, Nowak-Göttl U.

Methods Mol Biol. 2013;992:407-12. doi: 10.1007/978-1-62703-339-8_33.

PMID:
23546733
45.

Venous thromboembolism in neonates and children--update 2013.

Nowak-Göttl U, Janssen V, Manner D, Kenet G.

Thromb Res. 2013 Jan;131 Suppl 1:S39-41. doi: 10.1016/S0049-3848(13)70019-7.

PMID:
23452739
46.

Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort study.

Lambers M, Goldenberg NA, Kenet G, Kirkham FJ, Manner D, Bernard T, Mesters RM, Junker R, Stoll M, Nowak-Göttl U.

Ann Neurol. 2013 Jan;73(1):58-64. doi: 10.1002/ana.23735. Epub 2012 Dec 7.

47.

A genome-wide association study identifies a gene network of ADAMTS genes in the predisposition to pediatric stroke.

Arning A, Hiersche M, Witten A, Kurlemann G, Kurnik K, Manner D, Stoll M, Nowak-Göttl U.

Blood. 2012 Dec 20;120(26):5231-6. doi: 10.1182/blood-2012-07-442038. Epub 2012 Sep 18.

48.

Venous thromboembolism in neonates and children.

Kenet G, Nowak-Göttl U.

Best Pract Res Clin Haematol. 2012 Sep;25(3):333-44. doi: 10.1016/j.beha.2012.07.001. Epub 2012 Aug 15. Review.

PMID:
22959549
49.

Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study.

Holzhauer S, Goldenberg NA, Junker R, Heller C, Stoll M, Manner D, Mesters R, Krümpel A, Stach M, Nowak-Göttl U.

Blood. 2012 Aug 16;120(7):1510-5. doi: 10.1182/blood-2012-01-405514. Epub 2012 May 11.

50.

EPNS/SFNP guideline on the anticoagulant treatment of cerebral sinovenous thrombosis in children and neonates.

Lebas A, Chabrier S, Fluss J, Gordon K, Kossorotoff M, Nowak-Göttl U, de Vries LS, Tardieu M; French Society for Paediatric Neurology; European Paediatric Neurology Society.

Eur J Paediatr Neurol. 2012 May;16(3):219-28. doi: 10.1016/j.ejpn.2012.02.005. Epub 2012 Mar 16.

PMID:
22425391

Supplemental Content

Loading ...
Support Center